Pulse Biosciences, Inc.
PLSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -50.6% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -1,606.3% | -38.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -8,100.3% | -4,363% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -8,357.9% | -4,489.4% |
| EPS Diluted | -0.92 | -0.88 | -1.72 | -2.28 |
| % Growth | -4.5% | 48.8% | 24.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |